Aug 6, 2026 07:00AM

Jun 13, 2026 07:30AM

Jun 13, 2026 07:30AM

Jun 1, 2026 07:30AM

Jun 1, 2026 07:30AM

May 11, 2026 07:30AM

Apr 27, 2026 02:50PM Intellia Therapeutics (NTLA) PT Raised to $30 at Chardan

Apr 27, 2026 10:10AM

Apr 27, 2026 07:03AM

Apr 27, 2026 07:00AM

Apr 27, 2026 07:00AM

Apr 27, 2026 07:00AM

Apr 8, 2026 09:15AM

Mar 4, 2026 06:01AM Jones Trading Upgrades Intellia Therapeutics (NTLA) to Buy

Mar 3, 2026 09:54AM

Mar 3, 2026 07:30AM

Mar 3, 2026 07:30AM

Mar 3, 2026 04:56AM

Mar 2, 2026 03:25PM

Mar 2, 2026 02:48PM

Mar 2, 2026 02:18PM Intellia Therapeutics (NTLA) PT Raised to $27 at Chardan

Mar 2, 2026 02:04PM

Mar 2, 2026 12:28PM

Mar 2, 2026 12:05PM

Mar 2, 2026 10:25AM

Mar 2, 2026 07:30AM

Mar 2, 2026 07:30AM

Feb 26, 2026 01:28PM TD Cowen Reiterates Buy Rating on Intellia Therapeutics (NTLA)

Feb 26, 2026 07:30AM

Jan 27, 2026 11:29AM

Jan 27, 2026 08:00AM

Jan 27, 2026 08:00AM

Dec 19, 2025 09:06AM

Nov 18, 2025 08:45AM

Nov 10, 2025 03:17PM Intellia reports 3-year durability data for ATTR amyloidosis treatment

Nov 10, 2025 03:17PM

Nov 8, 2025 05:13PM

Nov 8, 2025 05:13PM

Nov 7, 2025 08:56AM

Nov 6, 2025 04:00PM

Oct 31, 2025 09:54AM

Oct 31, 2025 07:27AM BofA Securities Downgrades Intellia Therapeutics (NTLA) to Neutral, 'FDA pause lowers contribution from key value driver'

Oct 30, 2025 04:55AM

Oct 29, 2025 04:24PM

Oct 28, 2025 06:26AM

Oct 27, 2025 07:31AM

Oct 27, 2025 07:30AM

Sep 18, 2025 07:30AM

Sep 18, 2025 07:30AM Intellia Therapeutics Completes Enrollment in the Global Phase 3 HAELO Study of Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema

Aug 30, 2025 04:00PM

329,911 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All